메뉴 건너뛰기




Volumn 372, Issue 3, 2015, Pages 275-277

A new era for the treatment of hyperkalemia?

(1)  Ingelfinger, Julie R a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PATIROMER; POTASSIUM; SODIUM ZIRCONIUM CYCLOSILICATE; POLYMER; SILICATE;

EID: 84920996932     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1414112     Document Type: Editorial
Times cited : (58)

References (7)
  • 1
    • 0001112220 scopus 로고
    • The effect in humans of extracellular pH change on the relationship between serum potassium concentration and intracellular potassium
    • Burnell JM, Scribner BH, Uyeno BT, Villamil MF. The effect in humans of extracellular pH change on the relationship between serum potassium concentration and intracellular potassium. J Clin Invest 1956;35:935-9.
    • (1956) J Clin Invest , vol.35 , pp. 935-939
    • Burnell, J.M.1    Scribner, B.H.2    Uyeno, B.T.3    Villamil, M.F.4
  • 2
    • 84908248239 scopus 로고    scopus 로고
    • Management of hyperkalaemia in chronic kidney disease
    • Kovesdy CP. Management of hyperkalaemia in chronic kidney disease. Nat Rev Nephrol 2014;10:653-62.
    • (2014) Nat Rev Nephrol , vol.10 , pp. 653-662
    • Kovesdy, C.P.1
  • 3
    • 84896823634 scopus 로고    scopus 로고
    • Sequential RAAS blockade: Is it worth the risk
    • Persson F, Rossing P. Sequential RAAS blockade: is it worth the risk? Adv Chronic Kidney Dis 2014;21:159-65.
    • (2014) Adv Chronic Kidney Dis , vol.21 , pp. 159-165
    • Persson, F.1    Rossing, P.2
  • 5
    • 84920982556 scopus 로고    scopus 로고
    • Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
    • Weir MR, Bakris GL, Bushinsky DA, et al. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med 2015;372:211-21.
    • (2015) N Engl J Med , vol.372 , pp. 211-221
    • Weir, M.R.1    Bakris, G.L.2    Bushinsky, D.A.3
  • 6
    • 84920973726 scopus 로고    scopus 로고
    • Sodium zirconium cyclosilicate in hyperkalemia
    • Packham DK, Rasmussen HS, Lavin PT, et al. Sodium zirconium cyclosilicate in hyperkalemia. N Engl J Med 2015;372:222-31.
    • (2015) N Engl J Med , vol.372 , pp. 222-231
    • Packham, D.K.1    Rasmussen, H.S.2    Lavin, P.T.3
  • 7
    • 84914703676 scopus 로고    scopus 로고
    • Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: The HARMONIZE randomized clinical trial
    • November 17 (Epub ahead of print)
    • Kosiborod M, Rasmussen HS, Lavin P, et al. Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial. JAMA 2014 November 17 (Epub ahead of print).
    • (2014) JAMA
    • Kosiborod, M.1    Rasmussen, H.S.2    Lavin, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.